4//SEC Filing
Viking Therapeutics, Inc. 4
Accession 0001209191-17-002391
$VKTXCIK 0001607678operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 7:20 PM ET
Size
7.9 KB
Accession
0001209191-17-002391
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-01-05+95,000→ 95,000 totalExercise: $1.23From: 2018-01-05Exp: 2027-01-05→ Common Stock (95,000 underlying) - Award
Stock Option (Right to Buy)
2017-01-05+17,605→ 17,605 totalExercise: $1.23From: 2017-01-05Exp: 2027-01-05→ Common Stock (17,605 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the option will vest on each anniversary of the grant date.
- [F2]The Reporting Person's employment agreement with the Issuer entitles him to an annual cash bonus. The Reporting Person voluntarily elected to be paid 20% of his 2016 annual cash bonus in the form of an option to purchase shares of common stock of the Issuer.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001607678
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 7:20 PM ET
- Size
- 7.9 KB